Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Cash flows from operating activities:              
Net loss $ (4,831) $ (820) $ 1,346 $ (2,659) $ (5,651) $ (1,313)  
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:              
Depreciation and amortization 1,765   2,973   4,017 5,929  
Amortization and write off of debt issuance cost         156 87  
Amortization and write off of discount on long-term debt         1,585 3,664  
Change in contingent consideration from acquisitions         (1,748) (10,553)  
Non-cash lease expense         1,888 2,207  
Change in tax receivable agreement liability         0 1,975  
Bad debt expense         89 1,163  
Equity-based compensation 1,703   2,666   3,687 5,947  
Non-cash interest         (976) (747)  
Gain on disposal of assets and lease terminations         (718) (931)  
Change in contingent consideration receivable from Lindora         3,593 0  
Impairment of goodwill and other noncurrent assets 0   12,928   0 14,843  
Changes in assets and liabilities, net of effect of acquisition:              
Accounts receivable         1,432 (11,949)  
Inventories         (727) 2,624  
Prepaid expenses and other current assets         3,196 (4,146)  
Operating lease liabilities         (1,994) (1,934)  
Deferred costs         2,575 2,065  
Notes receivable, net         3 1  
Accounts payable         (11,173) (4,662)  
Accrued expenses         (20,577) 12,127  
Other current liabilities         1 (2,417)  
Deferred revenue         (6,407) (7,335)  
Other assets         198 1,296  
Other liabilities         1,824 400  
Net cash provided by (used in) operating activities         (25,727) 8,341  
Cash flows from investing activities:              
Purchases of property and equipment         (736) (1,992)  
Purchase of intangible assets         (707) (803)  
Notes receivable issued         0 (173)  
Notes receivable payments received         234 108  
Net cash used in investing activities         (1,209) (2,860)  
Cash flows from financing activities:              
Borrowings from long-term debt, net of original discount issue         0 10,000  
Payments on long-term debt         (2,625) (2,748)  
Debt issuance costs         0 (90)  
Payment of preferred stock dividend         0 (3,796)  
Borrowings from line of credit         10,000 0  
Payments of contingent consideration         0 (500)  
Payments for taxes related to net share settlement of restricted share units         (1,161) (2,097)  
Proceeds from issuance of common stock in connection with stock-based compensation plans         58 122  
Payments for distributions to Pre-IPO LLC Members         (176) (432)  
Loan to shareholder (Note 9)         (35) 0  
Net cash provided by financing activities         6,061 459  
Increase (decrease) in cash, cash equivalents and restricted cash         (20,875) 5,940  
Cash, cash equivalents and restricted cash, beginning of period   $ 45,863   $ 32,739 45,863 32,739 $ 32,739
Cash, cash equivalents and restricted cash, end of period $ 24,988   $ 38,679   24,988 38,679 $ 45,863
Supplemental cash flow information:              
Interest paid         31,129 20,444  
Income taxes paid, net         180 233  
Non-cash investing and financing activities::              
Capital expenditures accrued at period end         167 1,516  
Debt issuance costs paid-in-kind-long-term debt         0 10,872  
Debt issuance costs exit fees - long-term debt         $ 0 $ 7,248